Embryonic Stem Cell News and Research

RSS

Scientists discover new way to generate human motor nerve cells

Scientists have discovered a new way to generate human motor nerve cells in a development that will help research into motor neurone disease.

2 Mar 2011

Progeria-derived iPS cells may treat aging-related disease in children

The current pace of population aging is without parallel in human history but surprisingly little is known about the human aging process, because lifespans of eight decades or more make it difficult to study. Now, researchers at the Salk Institute for Biological Studies have replicated premature aging in the lab, allowing them to study aging-related disease in a dish.

24 Feb 2011

ACT receives patent for its single-blastomere technology

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has been issued a patent on its "single-blastomere" technique. Patent Number 7,893,315 broadly covers ACT's proprietary single-blastomere technology that provides a non-destructive alternative for deriving human embryonic stem cell lines.

23 Feb 2011

New research finds differences in cell fate commitment during embryonic development in mammals

New research shows that all not mammals are created equal. In fact, this work shows that the animals most commonly used by scientists to study mammalian genetics -- mice -- develop unusually quickly and may not always be representative of embryonic development in other mammals.

15 Feb 2011

Scholars urge scientific community to act against negative effects of patenting in stem cell field

In an opinion piece published Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of the patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law and common practice, the experts insist.

15 Feb 2011

BioTime to merge Glycosan with OrthoCyte

BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime's wholly-owned subsidiary, OrthoCyte Corporation. The acquisition is expected to close by March 18, 2011.

14 Feb 2011

Rare heart defect reproduced in petri dish, hope for cure

U.S. researchers have created beating heart cells in the lab with the same heart defect using skin cells taken from children with a rare heart defect. This means they can now test new drugs in human cells instead of mice.

13 Feb 2011

First 7 stem cell lines grown at UMMS Human Stem Cell Bank ready for global distribution

The first seven stem cell lines grown and banked at the University of Massachusetts Medical School's Human Stem Cell Bank are ready for worldwide distribution to researchers working on discovering new therapeutic treatments for diseases such as cancer, juvenile diabetes, Alzheimer's and Parkinson's, among others.

11 Feb 2011

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem-, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

11 Feb 2011

Scientists generate beating heart cells from skin cells of young patients with severe genetic heart defect

Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.

10 Feb 2011

Survey reveals negative impact of uncertain policy surrounding human embryonic stem cell research

While there is no doubt that the ethical controversy surrounding human embryonic stem cell (hESC) research has given rise to an uncertain policy environment, the true impact of years of frequent policy changes has not been fully assessed.

4 Feb 2011

Method to comprehensively characterize human embryonic stem cell lines and iPS cell lines

Ever since researchers devised a recipe for turning adult cells into cells that look and act like embryonic stem cells, there has been lingering doubt in the field about just how close to embryonic stem cells each of those cell lines really is at a molecular and functional level. Now, researchers reporting in the February 4th issue of the journal Cell, a Cell Press publication, have developed a systematic way to lay those doubts about quality to rest.

4 Feb 2011

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.

4 Feb 2011

Researchers find better way to create iPS cells from blood samples

Researchers at Johns Hopkins have found a better way to create induced pluripotent stem cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.

2 Feb 2011

Scientists devise safer way to create iPS cells

Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.

1 Feb 2011

Stem cell exhibition to broaden debate on the issue

The topic remains complex and controversial, the technology innovative and promising, and the debate, on stem-cell research, continues unabated. And now, the subject is receiving the attention of a group not normally associated with scientific discoveries. University of Alberta printmaking professor, Sean Caulfield, along with U of A Health Law Institute research director and researcher, Tim Caulfield, have brought together a group of visual artists from Europe and North America to contribute to the stem-cell debate that often pits politicians, scientists, pundits and religious leaders against each other.

17 Jan 2011

MGH researchers discover massive overexpression of DNA sequences in cancer cells

Massachusetts General Hospital Cancer Center researchers have discovered a previously unknown feature of common tumor cells - massive overexpression of certain DNA sequences that do not code for proteins.

14 Jan 2011

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

Scientists have developed Australia's first adult induced pluripotent stem cell lines using skin biopsies from patients with the rare genetic disease Friedreich Ataxia.

14 Jan 2011

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.

13 Jan 2011

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers at Nationwide Children's Hospital report a gene therapy strategy that improves the condition of a mouse model of an inherited blood disorder, Beta Thalassemia.

11 Jan 2011

Embryonic Stem Cell News and Research

Scientists discover new way to generate human motor nerve cells

Progeria-derived iPS cells may treat aging-related disease in children

ACT receives patent for its single-blastomere technology

New research finds differences in cell fate commitment during embryonic development in mammals

Scholars urge scientific community to act against negative effects of patenting in stem cell field

BioTime to merge Glycosan with OrthoCyte

Rare heart defect reproduced in petri dish, hope for cure

First 7 stem cell lines grown at UMMS Human Stem Cell Bank ready for global distribution

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Scientists generate beating heart cells from skin cells of young patients with severe genetic heart defect

Survey reveals negative impact of uncertain policy surrounding human embryonic stem cell research

Method to comprehensively characterize human embryonic stem cell lines and iPS cell lines

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

Researchers find better way to create iPS cells from blood samples

Scientists devise safer way to create iPS cells

Stem cell exhibition to broaden debate on the issue

MGH researchers discover massive overexpression of DNA sequences in cancer cells

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News